Bilateral Posterior Subthalamic Area Deep Brain Stimulation for Essential Tremor: A Case Series
Author(s) -
Xiaoyu Sun,
Luke Huang,
Yixin Pan,
Chencheng Zhang,
Tao Wang,
Hongxia Li,
Bomin Sun,
Jianqing Ding,
Yiwen Wu,
Dianyou Li
Publication year - 2020
Publication title -
frontiers in human neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.128
H-Index - 114
ISSN - 1662-5161
DOI - 10.3389/fnhum.2020.00016
Subject(s) - deep brain stimulation , medicine , adverse effect , dysarthria , subthalamic nucleus , essential tremor , quality of life (healthcare) , refractory (planetary science) , movement disorders , surgery , anesthesia , physical medicine and rehabilitation , parkinson's disease , disease , radiology , physics , nursing , astrobiology
Background Deep brain stimulation (DBS) of the posterior subthalamic area (PSA) provides a potentially effective treatment for medication-refractory essential tremor (ET). Objective To study the clinical benefits and adverse-event profile of bilateral PSA-DBS for refractory ET. Methods Seven patients with refractory ET underwent bilateral PSA-DBS surgery under general anesthesia between September 2017 and May 2018. Clinical outcome assessments, using the Essential Tremor Rating Scale, were performed at 1-, 6-, and 12-month follow-up, except for the last assessment of one patient who was followed up to 9 months. Analysis was focused on changes in patients’ motor symptoms and quality of life following surgery as well as documenting the adverse-event profile associated with the surgical PSA-DBS treatment. Results After surgery, patients’ motor symptoms, including upper limb tremor and head tremor, were improved by 84.2% and their quality of life by 81.25% at 1-month follow-up. The clinical benefits to patients were maintained at 6-month and last follow-up. Adverse side effects included dysarthria ( n = 4), balance disorder ( n = 2), and paresthesia of the right limb ( n = 1). No habituation effects were observed throughout the follow-up. Conclusion Bilateral PSA-DBS seems to offer an effective and safe alternative treatment for medically intractable ET, warranting further research into its clinical utility, adverse-event profile, and comparative effectiveness.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom